Comparison of intranasal midazolam and Dexmedetomidine

Not Applicable

• Conditions: Sedation.; Phobic anxiety disorder of childhood; F-93.1

• Registration Number: IRCT201409141861N5
• Lead Sponsor: Vice chnceller of research and technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Uncooperative pediatric dental patients; age 4 to 6 years; negative or definitely negatively Behavioral; healthy (ASA I); need at least one dental appointment including injection and pulp treatment.
Exclusion criteria: History of allergy to either administered agents or other sedatives; sleep apnea; delayed in growth; mental retardation; allergic reaction to other sedatives or general anesthesia; nonacceptance of drug administration;upper respiratory infection or nasal secretions during the past two weeks.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified